Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Perrigo Acquires Rosemont Pharmaceuticals
Feb. 12, 2013
Perrigo acquired Rosemont Pharmaceuticals for roughly $283 million in a deal that expands the brand drugmaker’s international presence and complements its UK OTC business.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing